Parnian Shobeiri
- Infectious Diseases top 5%
- Neurology top 5%
- Molecular Biology
- Epidemiology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Nima RezaeiAmirali KarimiArutha KulasingheAntônio Lúcio TeixeiraSara MomtazmaneshSahar Saeedi MoghaddamBagher LarijaniNegar Rezaei
- Topics
- COVID-19 Clinical Research Studies (13 papers)Multiple Sclerosis Research Studies (9 papers)Radiomics and Machine Learning in Medical Imaging (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEFrontiers in Immunology
- Partner nations
- IranUnited StatesGermany
In The Last Decade
Parnian Shobeiri
96 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 127
- Infectious Diseases 267
- Neurology 203
- Molecular Biology 193
- Epidemiology 170
- Pathology and Forensic Medicine 159
Countries citing papers authored by Parnian Shobeiri
This map shows the geographic impact of Parnian Shobeiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parnian Shobeiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parnian Shobeiri more than expected).
Fields of papers citing papers by Parnian Shobeiri
This network shows the impact of papers produced by Parnian Shobeiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parnian Shobeiri. The network helps show where Parnian Shobeiri may publish in the future.
Co-authorship network of co-authors of Parnian Shobeiri
This figure shows the co-authorship network connecting the top 25 collaborators of Parnian Shobeiri. A scholar is included among the top collaborators of Parnian Shobeiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parnian Shobeiri. Parnian Shobeiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 12 | |
| 5 | 5 | |
| 6 | 44 | |
| 7 | 7 | |
| 8 | 10 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 14 | |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 6 | |
| 15 | 9 | |
| 16 | 11 | |
| 17 | 64 | |
| 18 | 18 | |
| 19 | 102 | |
| 20 | 39 |
About Parnian Shobeiri
Parnian Shobeiri is a scholar working on Health Informatics, General Dentistry and Neurology, having authored 102 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Multiple Sclerosis Research Studies (9 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). The work is most often cited by research in Health Informatics (22 citations), Infectious Diseases (267 citations) and Biological Psychiatry (35 citations). Parnian Shobeiri has collaborated with scholars based in Iran, United States and Germany. Frequent co-authors include Nima Rezaei, Amirali Karimi, Arutha Kulasinghe, Antônio Lúcio Teixeira, Sara Momtazmanesh, Sahar Saeedi Moghaddam, Bagher Larijani, Negar Rezaei, António Teixeira and Sara Hanaei. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.